首页 > 市场调查报告书 > 医疗设备

医学影像诊断内视镜检查设备

市场调查报告书

商品编码

1629831

日本内科治疗设备市场 - 2024-2031

Japan Endotherapy Devices Market - 2024-2031

出版日期: 2024年12月30日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

日本腔内治疗设备市场在 2023 年达到 27 亿美元，预计到 2031 年将达到 44.4 亿美元，2024-2031 年预测期间复合年增长率为 6.4%。

内视镜设备是用于可视化和检查内部器官和结构的医疗仪器，从而实现微创诊断和治疗。它们在胃肠病学、肺病学、妇科和骨科等领域至关重要，可促进大肠镜检查、支气管镜检查和腹腔镜检查等手术。高清和 3D 视觉化等影像技术的进步提高了准确性和精确度，减少了侵入性手术的需要并促进患者更快康復。

市场动态：

驱动程式和限制

内视镜设备的技术进步

由于高清成像、3D 视觉化和人工智慧辅助诊断等技术进步，内视镜设备市场正在成长。这些技术提高了内视镜手术的精确度和效率，使医生能够更准确地检测异常情况。人工智慧驱动的演算法增强了即时影像分析，识别表明癌症或息肉等疾病的模式。胶囊内视镜为胃肠道诊断提供了一种对患者更友善的方法。灵活的机器人内视镜提高了复杂手术中的可操作性和可及性，最大限度地减少组织创伤和恢復时间。

例如，2024年10月，奥林巴斯公司推出了智慧内视镜生态系统，这是一个整合硬体、软体、服务和资料的综合医疗技术系统，以提高临床决策和营运效率。

「智慧内视镜生态系统」是对内视镜未来的愿景，专注于无缝通讯和智慧组件。该系统使用人工智慧演算法来改善患者治疗效果和营运效率，使医院和内科医生受益。临床环境中产生的数据和不同软体的应用将增强系统的功能。

成本高且可近性有限

内视镜设备和手术由于成本高而面临严重的市场限制，这使得许多医疗机构难以承担，特别是在低收入和中等收入国家。维护和维修费用也增加了财务负担，限制了它们在资源有限的环境中的采用。缺乏熟练的专业人员来操作这些复杂的设备使问题更加复杂化，特别是在农村和服务不足的地区。这种差异导致诊断和治疗延迟，对患者的治疗结果产生负面影响。儘管努力开发具有成本效益的解决方案并培训医疗保健专业人员，但这些挑战仍然存在。

例如，基本内视镜系统、双极钳主体系统和高速钻主体系统的初始成本分别为4,500,000日元、3,500,000日元和3,035,000日元，不包括视讯设备。儘管成本效益高且以患者为中心的临床结果，但医院管理层仍难以适当地提供 FELD，儘管需要视讯设备和相容的视讯设备。

Endoscopy devices are medical instruments used to visualize and examine internal organs and structures, enabling minimally invasive diagnosis and treatment. They are crucial in fields like gastroenterology, pulmonology, gynecology, and orthopedics, facilitating procedures like colonoscopy, bronchoscopy, and laparoscopy. Advancements in imaging technologies, such as high-definition and 3D visualization, enhance accuracy and precision, reducing the need for invasive surgeries and promoting faster patient recovery.

Market Dynamics: Drivers & Restraints

Technological Advancements in Endoscopy Devices

The endoscopy devices market is growing due to technological advancements like high-definition imaging, 3D visualization, and AI-assisted diagnostics. These technologies improve the precision and efficiency of endoscopic procedures, enabling physicians to detect abnormalities more accurately. AI-powered algorithms enhance real-time image analysis, identifying patterns indicative of conditions like cancer or polyps. Capsule endoscopy offers a more patient-friendly approach to gastrointestinal diagnostics. Flexible robotic endoscopes improve maneuverability and accessibility in complex procedures, minimizing tissue trauma and recovery time.

For instance, in October 2024, Olympus Corporation introduced the Intelligent Endoscopy Ecosystem, a comprehensive medical technology system that integrates hardware, software, services, and data to improve clinical decision-making and operational efficiency.

The "Intelligent Endoscopy Ecosystem" is a vision for the future of endoscopy, focusing on seamless communication and intelligent components. This system uses AI algorithms to improve patient outcomes and operational efficiencies, benefiting hospitals and doctors in the endosuite. Data generated in clinical settings and the application of different software will enhance the system's capabilities.

High Costs and Limited Accessibility

Endoscopy devices and procedures face significant market restraint due to their high costs, which make them unaffordable for many healthcare facilities, especially in low- and middle-income countries. Maintenance and repair expenses also add to the financial burden, limiting their adoption in resource-constrained settings. The lack of skilled professionals to operate these sophisticated devices further complicates the issue, particularly in rural and underserved areas. This disparity results in delayed diagnoses and treatments, negatively impacting patient outcomes. Despite efforts to develop cost-effective solutions and train healthcare professionals, these challenges persist.

For instance, The initial costs for basic endoscope systems, bipolar forceps main body systems, and high-speed drill main body systems are ¥4,500,000, ¥3,500,000, and ¥3,035,000, respectively, excluding video equipment. Despite the high cost-effectiveness and patient-centered clinical outcomes, hospital management struggles to provide FELD appropriately, despite the need for video equipment and compatible video equipment.

Segment Analysis

The Japan endotherapy devices market is segmented based on product type, application and end user.

Product Type:

Endoscopes segment is expected to dominate the endotherapy devices market share

The endoscopes segment holds a major portion of the endotherapy devices market share and is expected to continue to hold a significant portion of the endotherapy devices market share during the forecast period.

Japan's endotherapy devices market is dominated by endoscopes, which are essential for minimally invasive medical procedures. With an aging population and increasing prevalence of gastrointestinal and chronic diseases, Japan has seen a surge in demand for endoscopic interventions. Endoscopes enable precise visualization and access to internal organs for diagnostic and therapeutic purposes, and are widely used in procedures like polypectomy, hemostasis, and stent placements. Japan's robust healthcare infrastructure and focus on preventive care have fueled the adoption of advanced endoscopic technologies, solidifying their crucial role in the nation's endotherapy devices landscape.

Moreover, novel product launches also help the segment to grow during the forecast period, for instance, in October 2024, Olympus has launched two bronchoscopes as part of its EVIS X1 Endoscopy System, which offers the latest in diagnostic and therapeutic bronchoscopy. The bronchoscopes feature slim outer diameters and large working channels, offering access to more distal airways. They are designed with high-definition imaging, allowing for improved suction and flexibility during procedures. The system also allows for the passage of a wide array of diagnostic and therapeutic devices through large working channels, providing physicians with options to successfully address the tracheal bronchial tree.

Gynecology endoscopy segment is the fastest-growing segment in the endotherapy devices market share

The gynecology endoscopy segment is the fastest-growing segment in the endotherapy devices market share and is expected to hold the market share over the forecast period.

Japan's hospitals are key providers of hemodialysis services, offering comprehensive services like patient monitoring, emergency care, and individualized treatment plans. With a universal healthcare system and specialized nephrology departments, hospitals are central to delivering dialysis treatments to the growing patient population.

Gynecology endoscopy is a key component in Japan's endotherapy devices market, focusing on advanced healthcare solutions for women's health. This minimally invasive technique is used for diagnosing and treating gynecological conditions like endometriosis, uterine fibroids, ovarian cysts, and infertility-related issues. With growing awareness of reproductive health and demand for early diagnosis, gynecological endoscopic procedures like hysteroscopy and laparoscopy have gained popularity. These procedures offer reduced pain, shorter recovery times, and minimal scarring, catering to Japan's aging and health-conscious population.

For instance, in September 2024, Olympus Corporation has launched a new 4K camera head, CH-S700-08-LB, for endoscopic urology and gynecology procedures in Europe. The head is compatible with the VISERA ELITE III video system center for surgical endoscopy. The product will be launched in Japan, Hong Kong, and Singapore in September 2024, following regulatory compliance. The technical development was led by Sony Olympus Medical Solutions Corporation, a joint venture between Olympus and Sony Corporation.

Competitive Landscape

The major Japan players in the endotherapy devices market include Olympus Corporation, HOYA Corporation (Pentax Medical), Fujifilm Holdings Corporation, Sumitomo Bakelite Co., Ltd., Shinko Optical Co., Ltd, TOP Corporation, KARL STORZ Japan K.K., Nipro Corporation, Terumo Corporation, Hitachi Ltd. among others.

Emerging Players

The emerging players in the endotherapy devices market include JMS Co., Ltd, Matsunami Glass Ind., Ltd, Asahi Intecc Co., Ltd, Nissha Medical Technologies, Kuraray Co., Ltd, Sysmex Corporation among others.

Key Developments

In October 2023, Olympus has introduced its next-generation EVIS X1 endoscopy system for gastrointestinal practitioners, along with GIF-1100 and CF-HQ1100DL/I compatible endoscopes. The GIF-1100 is for the upper digestive tract, while the CF-HQ1100DL/I is for the lower digestive tract. The system received approval earlier this year.
In November 2023, Olympus Corporation has launched its next-generation EVIS X1 endoscopy system in China, marking its availability in all of Olympus' major markets. The advanced system, first released in Europe, Japan, and the U.S. in April 2020, has now received clearance in China, marking its first launch in China since its launch in Europe, Japan, and the U.S. in October 2023.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan endotherapy devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Component & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.

Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End User

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Technological Advancements in Endoscopy Devices
4.2. Restraints
- 4.2.1. High Costs and Limited Accessibility
4.3. Opportunity
- 4.3.1. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Endoscopes *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Endoscopic Operative Devices
6.4. Endoscopic Visualization Devices

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Gynecology Endoscopy*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Gastrointestinal (GI) Endoscopy
7.4. Bronchoscopy
7.5. Urology Endoscopy
7.6. Arthroscopy
7.7. Laparoscopy

8. By End User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 8.1.2. Market Attractiveness Index, By End User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgical Centers (ASCs)
8.4. Specialty Clinics

9. Competitive Landscape

9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis

10. Company Profiles

10.1. Olympus Corporation*
- 10.1.1. Company Overview
- 10.1.2. Product Portfolio and Description
- 10.1.3. Financial Overview
- 10.1.4. Key Developments
10.2. HOYA Corporation (Pentax Medical)
10.3. Fujifilm Holdings Corporation
10.4. Sumitomo Bakelite Co., Ltd.
10.5. Shinko Optical Co., Ltd.
10.6. TOP Corporation
10.7. KARL STORZ Japan K.K.
10.8. Nipro Corporation
10.9. Terumo Corporation
10.10. Hitachi Ltd

LIST NOT EXHAUSTIVE